Effects of the 5-HT4 receptor agonist RS67333 and paroxetine on hippocampal extracellular 5-HT levels

Neuroscience Letters

Volumn 476, Issue 2, 2010, Pages 58-61

  Licht, Cecilie Löe ^a   Knudsen, Gitte Moos ^a   Sharp, Trevor ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

5 HT4 receptor; 5 Hydroxytryptamine; Hippocampus; In vivo microdialysis; Paroxetine; RS67333

Indexed keywords

1 (4 AMINO 5 CHLORO 2 METHOXYPHENYL) 3 (1 BUTYL 4 PIPERIDINYL) 1 PROPANONE; 5 HYDROXYINDOLEACETIC ACID; CHLORAL HYDRATE; PAROXETINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENTIATION; HIPPOCAMPUS; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANILINE COMPOUNDS; ANIMALS; DRUG SYNERGISM; EXTRACELLULAR SPACE; HIPPOCAMPUS; HYDROXYINDOLEACETIC ACID; MALE; MICRODIALYSIS; PAROXETINE; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 77952753353     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.04.002     Document Type: Article

References (24)

1. Boothman L.J., Allers K.A., Rasmussen K., Sharp T. Evidence that central 5-HT2A and 5-HT2B/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat. Br. J. Pharmacol. 2003, 139:998-1004.
2. Boothman L.J., Mitchell S.N., Sharp T. Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis. Neuropharmacology 2006, 50:726-732.
3. Bourin M., Chue P., Guillon Y. Paroxetine: a review. CNS Drug Rev. 2001, 7:25-47.
4. Compan V., Daszuta A., Salin P., Sebben M., Bockaert J., Dumuis A. Lesion study of the distribution of serotonin 5-HT4 receptors in rat basal ganglia and hippocampus. Eur. J. Neurosci. 1996, 8:2591-2598.
5. Eglen R.M., Bonhaus D.W., Johnson L.G., Leung E., Clark R.D. Pharmacological characterization of two novel and potent 5-HT4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivo. Br. J. Pharmacol. 1995, 115:1387-1392.
6. Frankfurt M, McKittrick C.R., Luine V.N. Short-term fluoxetine treatment alters monoamine levels and turnover in discrete brain nuclei. Brain Res. 1994, 650:127-132.
7. Gartside S.E., Umbers V., Hajos M., Sharp T. Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol. 1995, 115:1064-1070.
8. Ge J., Barnes N.M. 5-HT4 receptor-mediated modulation of 5-HT release in the rat hippocampus in vivo. Br. J. Pharmacol. 1996, 117:1475-1480.
9. Hajos-Korcsok E., McTavish S.F., Sharp T. Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine. Eur. J. Pharmacol. 2000, 407:101-107.
10. Hajos M., Gartside S.E., Sharp T. Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine. Naunyn Schmiedebergs Arch. Pharmacol. 1995, 351:624-629.
11. Hjorth S. Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study. J. Neurochem. 1993, 60:776-779.
12. Invernizzi R., Bramante M., Samanin R. Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors. Eur. J. Pharmacol. 1994, 260:243-246.
13. Kreiss D.S., Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharmacol. Exp. Ther. 1995, 274:866-876.
14. Licht C.L., Marcussen A.B., Wegener G., Overstreet D.H., Aznar S., Knudsen G.M. The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration. J. Neurochem. 2009, 109:1363-1374.
15. Lucas G., Compan V., Charnay Y., Neve R.L., Nestler E.J., Bockaert J., Barrot M., Debonnel G. Frontocortical 5-HT4 receptors exert positive feedback on serotonergic activity: viral transfections, subacute and chronic treatments with 5-HT4 agonists. Biol. Psychiatry 2005, 57:918-925.
16. Lucas G, Debonnel G. 5-HT4 receptors exert a frequency-related facilitatory control on dorsal raphe nucleus 5-HT neuronal activity. Eur. J. Neurosci. 2002, 16:817-822.
17. Lucas G., Rymar V.V., Du J., Mnie-Filali O., Bisgaard C., Manta S., Lambas-Senas L., Wiborg O., Haddjeri N., Pineyro G., Sadikot A.F., Debonnel G. Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action. Neuron 2007, 55:712-725.
18. Miguez J.M., Paz-Valinas L., Miguez I., Aldegunde M. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study. Naunyn Schmiedebergs Arch. Pharmacol. 2002, 365:378-387.
19. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
20. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2005, Elsevier, Academic Press. 5th ed.
21. Sharp T., Bramwell S.R., Clark D., Grahame-Smith D.G. In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity. J. Neurochem. 1989, 53:234-240.
22. Sharp T., Umbers V., Gartside S.E. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo. Br. J. Pharmacol. 1997, 121:941-946.
23. Sharp T., Zetterström T. In vivo measurement of monoamine neurotransmitter release using brain microdialysis. Monitoring Neuronal Activity. A Practical Approach 1992, 147-179. Oxford University Press, Oxford. J.A. Stamford (Ed.).
24. Sprouse J.S., Aghajanian G.K. Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1987, 1:3-9.